Success Stories: Premium Processing Upgrade and Our Collaboration Aid to a Turkish Founder and Principal Consultant Working in the Biomedical Science Field, Secured him NIW Approval in Just 2 Days

Posted by wegreened on December 15, 2023 in NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“Thanks a lot for the update. I didn't expect it to be approved so quickly, it was a surprise for me!!!”

On August 24^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Founder and Principal Consultant in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Founder and Principal Consultant

Country of Origin: Turkey

Country of Residence at the Time of Filing: Turkey

Approval Notice Date: August 24^th, 2023

Processing Time: 2 days (Premium Processing Requested)

Case Summary:

When our Turkish EB2-NIW (National Interest Waiver) client sought to file his petition, we made sure to include the following details in his NIW petition packet:

We detailed our client’s proposed endeavor to continue his research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays, in order to improve cancer diagnosis and treatment, as well as evaluate and reduce the toxicity of biomedical materials and devices.
We deduced that his research is of great importance because it provides innovative technologies that underpin increasingly effective cancer treatments. Cancer was the cause of nearly 10 million deaths in 2020 alone, accounting for approximately one out of every six deaths worldwide.
We added how his research also has broad implications for the United States. Innovations like our client’s nanoparticle-based anticancer drug delivery systems are essential to reducing cancer mortality, improving population health, and decreasing financial burdens nationwide.
Additionally, due to its clear national importance, his research has been supported with funding from the Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Not only this, but he has even completed at least 11 reviews to date. His research has resulted in 12 peer-reviewed journal articles (8 of them first-authored) and these publications have been cited a total of 259 times according to Google Scholar.

Considering his track record of successful research in an area that significantly advances US interests, he provides contributions of such value that, on balance, they would benefit the US even if other qualified US workers were available. His work directly tackles crucial concerns concerning the development of effective cancer therapies and the improvement of public health. Therefore, he won the NIW approval in just 2 days. Because of the premium processing upgrade, this was the quickest approval. Premium Processing is a paid option provided by the USCIS that allows petitioners to receive rapid adjudication (the case will be completed in 15 days rather than 9-12 months). We are pleased to have had the opportunity to represent his NIW case and wish him the best of luck in his future efforts.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%